JPY5,829.00
0.68%
Tokyo, Sep 13, 08:15 am CET
ISIN
JP3160400002
Symbol
4523
Index
Sector
Industry

Eisai Stock price

JPY5,829.00
+154.00 2.71% 1M
-659.00 10.16% 6M
-1,223.00 17.34% YTD
-3,091.00 34.65% 1Y
-2,458.00 29.66% 3Y
+309.00 5.60% 5Y
+1,479.00 34.00% 10Y
Tokyo, Closing price Fri, Sep 13 2024
-40.00 0.68%
ISIN
JP3160400002
Symbol
4523
Index
Sector
Industry

Key metrics

Market capitalization JPY1.67t
Enterprise Value JPY1.57t
P/E (TTM) P/E ratio 51.20
EV/FCF (TTM) EV/FCF 64.25
EV/Sales (TTM) EV/Sales 2.14
P/S ratio (TTM) P/S ratio 2.27
P/B ratio (TTM) P/B ratio 1.86
Dividend yield 2.74%
Last dividend (FY25) JPY160.00
Revenue growth (TTM) Revenue growth -3.07%
Revenue (TTM) Revenue JPY733.85b
EBIT (operating result TTM) EBIT JPY25.18b
Free Cash Flow (TTM) Free Cash Flow JPY24.40b
Cash position JPY303.94b
EPS (TTM) EPS JPY113.86
P/E forward 35.30
P/S forward 2.17
EV/Sales forward 2.04
Show more

Is Eisai a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Eisai Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Eisai forecast:

8x Buy
50%
6x Hold
38%
2x Sell
13%

Analyst Opinions

16 Analysts have issued a Eisai forecast:

Buy
50%
Hold
38%
Sell
13%

Financial data from Eisai

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '24
+/-
%
741,751 741,751
0% 0%
100%
- Direct Costs 177,977 177,977
11% 11%
24%
563,774 563,774
4% 4%
76%
- Selling and Administrative Expenses 324,532 324,532
6% 6%
44%
- Research and Development Expense 153,092 153,092
2% 2%
21%
86,150 86,150
9% 9%
12%
- Depreciation and Amortization 39,398 39,398
1% 1%
5%
EBIT (Operating Income) EBIT 46,752 46,752
19% 19%
6%
Net Profit 42,407 42,407
23% 23%
6%

In millions JPY.

Don't miss a Thing! We will send you all news about Eisai directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Haruo Naito
Employees 11,067
Founded 1936
Website www.eisai.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today